Abstract:In this study, we use cationic imidazole as the targeting group and phenoxazine as the electron donor, attaching phenoxazine to porphyrin via two different linking methods to synthesize two different phenoxazine-porphyrin photosensitizers (PSs), P1 and P2 , intended for photodynamic therapy (PDT) applications. Additionally, we synthesized a molecule, P3 , that does not contain the cationic imidazole group, to serve as a control PS. We comprehensively evaluate the performance of P1 and P2 through steady-state and transient spectroscopy analysis, theoretical calculations, photooxidation experiments, and in vitro cell experiments. The results showed that P1 and P2 exhibit excellent water solubility, longer triplet state lifetimes ( P1 at 200 μs, P2 at 170 μs), outstanding photostability, higher photooxidation rates and quantum yields of singlet oxygen ( 1 O 2 ). Notably, in the photooxidation experiment, P1 's photooxidation rate is 1.1 times that of P2 , and 1.5 times that of tetraphenyl zinc porphyrin (ZnTPP) without phenothiazine. This may be due to the larger Gibbs free energy difference between the singlet and triplet excited states in P1 (Δ G S-T of P1 is 0.87 eV, compared to 0.83 eV for P2 ), which results in a greater driving force for intersystem crossing (ISC) in P1 than in P2 . The introduction of the cationic imidazole group in P1 and P2 significantly enhances water solubility and tumor cell uptake compared to P3 , particularly showing higher intracellular accumulation and 1 O 2 generation capabilities in HepG2 tumor cells. Flow cytometry test results further confirmed the significant photocytotoxicity of P1 and P2 , with a marked decrease in survival rates after light exposure, where the survival rate of P1 nanoparticles (NPs) dropped to 41.7%, P2 NPs to 35.1%, and P3 NPs to 75.0%. The findings of this study provide crucial theoretical support for the design of new PSs.

A 2-pyridone modified zinc phthalocyanine with three-in-one multiple functions for photodynamic therapy

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

An intelligent ZIF-8-gated polydopamine nanoplatform for in vivo cooperatively enhanced combination phototherapy

Zinc phthalocyanine-bridged periodic mesoporous organosilica nanoparticle as biodegradable photosensitizer for photodynamic therapy

A Novel Multi-Effect Photosensitizer for Tumor Destruction via Multimodal Imaging Guided Synergistic Cancer Phototherapy

A diketopyrrolopyrrole-based conjugated polymer for efficient photodynamic and photothermal combination therapy under single 808 nm laser irradiation

A Nanoencapsulated Ir(III)-Phthalocyanine Conjugate as a Promising Photodynamic Therapy Anticancer Agent

Photosensitizer-Free Nanophosphor-Based theranostic probe for controllable photodynamic and photothermal visualization therapy

The epidemiology of leishmaniases in Lebanon.

Zinc Phthalocyanine Encapsulated in Polymer Micelles As a Potent Photosensitizer for the Photodynamic Therapy of Osteosarcoma.

Phototherapeutic applications of benzophenone-containing NIR-emitting photosensitizers based on different receptor modulations

Rational design of a meso phosphate-substituted pyronin as a type I photosensitizer for photodynamic therapy

Hydroxymethylhydroperoxide as inhibitor and peroxide substrate of horseradish peroxidase.

A Photosensitizer-Loaded Polydopamine Nanomedicine Agent for Synergistic Photodynamic and Photothermal Therapy

Recent advances of multi-dimensional porphyrin-based functional materials in photodynamic therapy

Synthesis of Three Cisplatin-Conjugated Asymmetric Porphyrin Photosensitizers for Photodynamic Therapy.

Synthesis of Asymmetric Cationic Zinc Porphyrin Photosensitizer Containing Thiophene Group for Photodynamic Therapy in Vitro and Theoretical Calculation of DFT

Phthalocyanine-based photosensitizers combined with anti-PD-L1 for highly efficient photodynamic immunotherapy

Synthesis and evaluation of novel mitochondria-targeted, water-soluble phenoxazine-porphyrins for efficient photodynamic therapy

A photoactive Ir–Pd bimetallic cage with high singlet oxygen yield for efficient one/two-photon activated photodynamic therapy

A Dual‐Functional Photosensitizer for Ultraefficient Photodynamic Therapy and Synchronous Anticancer Efficacy Monitoring